Is there any possibility it could have been a vaccine patch on the stethoscope? Did a little digging and got this answer from Brave AI:
Vaxxas HD-MAP Vaccine
Vaxxas, a clinical-stage biotechnology company, is developing a high-density microarray patch (HD-MAP) for needle-free vaccine delivery.
The HD-MAP is a small patch containing thousands of microscopic projections coated with vaccine, which delivers the dose just beneath the skin to abundant immune cells when applied with a special applicator.
This technology has been tested in clinical trials for vaccines against influenza, measles/rubella, and COVID-19, demonstrating safety, tolerability, and enhanced immune responses, sometimes at lower doses than traditional needle and syringe methods.
A key advantage of the HD-MAP is the potential for thermostable vaccine storage, as dried formulations on the patch can remain effective at temperatures up to 40°C for at least 12 months, reducing or eliminating the need for refrigeration during transport and storage.
Is there any possibility it could have been a vaccine patch on the stethoscope? Did a little digging and got this answer from Brave AI:
Vaxxas HD-MAP Vaccine
Vaxxas, a clinical-stage biotechnology company, is developing a high-density microarray patch (HD-MAP) for needle-free vaccine delivery.
The HD-MAP is a small patch containing thousands of microscopic projections coated with vaccine, which delivers the dose just beneath the skin to abundant immune cells when applied with a special applicator.
This technology has been tested in clinical trials for vaccines against influenza, measles/rubella, and COVID-19, demonstrating safety, tolerability, and enhanced immune responses, sometimes at lower doses than traditional needle and syringe methods.
A key advantage of the HD-MAP is the potential for thermostable vaccine storage, as dried formulations on the patch can remain effective at temperatures up to 40°C for at least 12 months, reducing or eliminating the need for refrigeration during transport and storage.